MarketCap
Facebook
X
TelegramQuarterly report 2024-Q4
added 02-21-2026
EDAP TMS S.A. ROA Ratio 2011-2026 | EDAP
Annual ROA Ratio EDAP TMS S.A.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -22.1 | -23.13 | -2.9 | 0.91 | -3.09 | 2.85 | -0.69 | -1.45 | 8.25 | -4.32 | -1.59 | -18.68 | -24.55 | -2.88 |
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 8.25 | -24.55 | -6.67 |
ROA Ratio of other stocks in the Medical devices industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acutus Medical
AFIB
|
-151.34 | - | -26.83 % | $ 2.62 M |  USA |
 |
LivaNova PLC
LIVN
|
-9.3 | $ 69.84 | 1.14 % | $ 3.79 B |  Britain |
 |
Allied Healthcare Products
AHPI
|
-9.84 | - | 3.58 % | $ 2.21 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-8.34 | - | - | $ 1.77 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
-2.42 | $ 6.61 | 3.44 % | $ 475 M |  Israel |
 |
Apollo Endosurgery
APEN
|
-36.14 | - | - | $ 475 M | USA |
 |
Lianluo Smart Limited
LLIT
|
-53.6 | - | 24.59 % | $ 44.8 M |  China |
 |
Alphatec Holdings
ATEC
|
-18.12 | $ 13.85 | -0.57 % | $ 2.08 B | USA |
 |
Avinger
AVGR
|
-133.04 | - | -20.74 % | $ 369 K | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-116.17 | - | -5.86 % | $ 30.6 M | USA |
 |
AxoGen
AXGN
|
-7.08 | $ 31.25 | -3.85 % | $ 1.44 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
-9.05 | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
-86.71 | - | 1.37 % | $ 20.5 M | USA |
 |
Apyx Medical Corporation
APYX
|
-23.62 | $ 3.46 | -2.26 % | $ 120 M | USA |
 |
Conformis
CFMS
|
-53.67 | - | - | $ 16.4 M | USA |
 |
Bio-Rad Laboratories
BIO
|
-7.64 | $ 269.55 | 0.25 % | $ 7.61 B | USA |
 |
BIOLASE
BIOL
|
-58.78 | - | -13.19 % | $ 166 K | USA |
 |
Bruker Corporation
BRKR
|
1.95 | $ 39.92 | 0.38 % | $ 5.95 K | USA |
 |
BioSig Technologies
BSGM
|
-1226.84 | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
6.62 | $ 74.02 | -1.5 % | $ 110 B | USA |
 |
CryoLife, Inc.
CRY
|
-2.11 | - | -4.14 % | $ 702 M | USA |
 |
ClearPoint Neuro
CLPT
|
-48.26 | $ 15.18 | 4.3 % | $ 410 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
-323.35 | - | 1.15 % | $ 34.5 M | USA |
 |
CONMED Corporation
CNMD
|
2.02 | $ 46.01 | -0.07 % | $ 1.43 B | USA |
 |
Soliton, Inc.
SOLY
|
-43.02 | - | -1.42 % | $ 435 M | USA |
 |
Cardiovascular Systems
CSII
|
-11.45 | - | 0.15 % | $ 844 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-86.69 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-17.05 | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
-8.55 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-37.58 | - | - | $ 111 M |  Canada |
 |
InMode Ltd.
INMD
|
12.24 | $ 13.96 | -0.14 % | $ 902 M | Israel |
 |
Cutera
CUTR
|
-16.53 | - | -10.19 % | $ 1.99 M | USA |
 |
Delcath Systems
DCTH
|
-34.45 | $ 10.16 | 2.11 % | $ 290 M | USA |
 |
Intersect ENT, Inc.
XENT
|
-31.81 | - | - | $ 955 M | USA |
 |
Dynatronics Corporation
DYNT
|
-70.61 | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-119.24 | - | - | $ 10.2 M | USA |
 |
Electromed
ELMD
|
14.01 | $ 23.53 | 1.64 % | $ 199 M | USA |
 |
Second Sight Medical Products
EYES
|
-56.51 | - | -0.97 % | $ 54.4 M | USA |
 |
Establishment Labs Holdings
ESTA
|
-24.39 | $ 77.39 | -2.87 % | $ 2.18 B |  Costa-rica |
 |
Nano-X Imaging Ltd.
NNOX
|
-25.48 | $ 2.46 | 1.23 % | $ 144 M | Israel |
 |
GBS
GBS
|
-128.11 | - | -0.57 % | $ 7.12 M | USA |
 |
FONAR Corporation
FONR
|
6.24 | $ 18.54 | -0.16 % | $ 122 M | USA |
 |
Globus Medical
GMED
|
10.14 | $ 95.57 | 3.99 % | $ 12.9 B | USA |
 |
Profound Medical Corp.
PROF
|
-35.38 | $ 7.35 | 2.79 % | $ 180 M | Canada |
 |
Helius Medical Technologies
HSDT
|
-115.05 | $ 2.18 | 17.84 % | $ 1.33 M | USA |
 |
IRadimed Corporation
IRMD
|
19.56 | $ 100.38 | 1.3 % | $ 1.27 B | USA |
 |
Invacare Corporation
IVC
|
-2.67 | - | - | $ 24.7 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
-0.17 | $ 11.54 | 0.09 % | $ 889 M | USA |
 |
Inogen
INGN
|
-12.12 | $ 6.07 | 3.94 % | $ 144 M | USA |